U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
130381130381The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk FactorsCompletedNo Results AvailableDiabetes|Cardiovascular RiskDietary Supplement: soy protein|Dietary Supplement: isoflavones|Dietary Supplement: milk proteinhttps://ClinicalTrials.gov/show/NCT00856882
130382130382Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy VolunteersCompletedNo Results AvailableHepatic Cirrhosis|Nonalcoholic SteatohepatitisDrug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972https://ClinicalTrials.gov/show/NCT00856869
130383130383ABSORB Clinical Investigation, Cohort BActive, not recruitingNo Results AvailableCoronary Disease|Coronary Artery Disease|Coronary RestenosisDevice: Bioabsorbable Everolimus Eluting Coronary Stenthttps://ClinicalTrials.gov/show/NCT00856856
130384130384BLI800-303: An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult SubjectsCompletedHas ResultsColonoscopyDrug: BLI800|Drug: Polyethylene glycol 3350 based bowel preparationhttps://ClinicalTrials.gov/show/NCT00856843
130385130385Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung CancerActive, not recruitingNo Results AvailableSmall Cell Lung Cancer|Extensive Stage Lung Cancer|ChemonaiveDrug: Bendamustine, Irinotecan, Etoposide/Carboplatin (Novel drug combination)https://ClinicalTrials.gov/show/NCT00856830
130386130386Heme Oxygenase (HO) Activity and Adenosine Induced VasodilationTerminatedNo Results AvailableAtherosclerotic Cardiovascular DiseaseDrug: L-arginine + heme arginate|Drug: Heme arginate + L-argininehttps://ClinicalTrials.gov/show/NCT00856817
130387130387Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon ResistanceRecruitingNo Results AvailableHepatitis CDrug: thalidomidehttps://ClinicalTrials.gov/show/NCT00856804
130388130388Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer PatientsCompletedHas ResultsOvarian CancerDrug: ON 01910.Nahttps://ClinicalTrials.gov/show/NCT00856791
130389130389Virtue® Male Incontinence Sling StudyCompletedHas ResultsStress Urinary IncontinenceDevice: Virtue® Male Incontinence Slinghttps://ClinicalTrials.gov/show/NCT00856778
130390130390Drug-eluting Balloon in Acute Myocardial InfarctionActive, not recruitingNo Results AvailableCoronary Artery Disease|Atherosclerosis|Thrombosis|Acute Myocardial InfarctionDevice: Drug eluting balloon|Device: Bare metal stent|Device: Drug eluting stenthttps://ClinicalTrials.gov/show/NCT00856765
130391130391Evaluation of the Pharmacokinetics of NRL972 Following Pre-Administration of Rifampicin and CyclosporineCompletedNo Results AvailablePharmacokineticsDrug: NRL972|Drug: NRL972|Drug: NRL972https://ClinicalTrials.gov/show/NCT00856752
130392130392Obesity and the Initiation of Knee OsteoarthritisCompletedHas ResultsObesityhttps://ClinicalTrials.gov/show/NCT00856739
130393130393Racial Differences in Phosphorus MetabolismCompletedNo Results AvailableHealthy VolunteersDrug: 1-34 parathyroid infusionhttps://ClinicalTrials.gov/show/NCT00856726
130394130394Clearance of NRL972 in Patients With Cirrhosis and in Healthy VolunteersCompletedNo Results AvailableHepatic CirrhosisDrug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972|Drug: NRL972https://ClinicalTrials.gov/show/NCT00856713
130395130395Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic SyndromeCompletedNo Results AvailableMetabolic SyndromeDrug: GLP-1 infusionhttps://ClinicalTrials.gov/show/NCT00856700
130396130396A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic SubjectsCompletedNo Results AvailableAsthmaDrug: PF-03893787|Drug: Placebo|Drug: Montelukasthttps://ClinicalTrials.gov/show/NCT00856687
130397130397Safety Study of of Intravenous CCL2-LPM in Patients With IgA NephropathyTerminatedNo Results AvailableIGA Nephropathy|ProteinuriaBiological: OPL-CCL2-LPMhttps://ClinicalTrials.gov/show/NCT00856674
130398130398Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)TerminatedNo Results AvailableStrokeDrug: Desmoteplase|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00856661
130399130399SmartPill Monitoring for Assessment of GI Function in SCICompletedNo Results AvailableSCIDevice: SmartPill ingestion and monitoringhttps://ClinicalTrials.gov/show/NCT00856648
130400130400A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)CompletedHas ResultsOptic NeuritisDrug: Glatiramer Acetate|Drug: placebohttps://ClinicalTrials.gov/show/NCT00856635
130401130401A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In PatientsCompletedNo Results AvailableOcular Hypertension|Glaucoma|Open-Angle GlaucomaDrug: i. Fixed combination of latanoprost 0.005% and timolol 0.5%|Drug: timolol 0.5% ophthalmic solution|Drug: latanoprost 0.005% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00856622
130402130402The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese SubjectsRecruitingNo Results AvailableWeight Loss|ObesityDrug: Byetta (exenatide)|Behavioral: Weight loss|Other: Metabolic Chamber|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00856609
130403130403Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and FemalesRecruitingNo Results AvailableTinea Pedis|Athlete's Foot|Foot Fungus|RingwormDrug: Sertaconazole nitrate cream 2%https://ClinicalTrials.gov/show/NCT00856596
130404130404Safety Study of Sertindole Versus Risperidone Under Normal Conditions of UseCompletedHas ResultsSchizophreniaDrug: Sertindole|Drug: Risperidonehttps://ClinicalTrials.gov/show/NCT00856583
130405130405A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy SubjectsCompletedNo Results AvailableOveractive Bladder|PharmacokineticsDrug: warfarin|Drug: YM178https://ClinicalTrials.gov/show/NCT00856570
130406130406Intervening to Prevent Contextual Errors in Medical Decision MakingCompletedHas ResultsPsychosocial CircumstancesBehavioral: Seminar and Practicumhttps://ClinicalTrials.gov/show/NCT00856557
130407130407A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedHas ResultsArthritis, RheumatoidDrug: CP-690,550|Drug: CP-690,550|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00856544
130408130408Impairments of Oral Language in Mobius SyndromeCompletedNo Results AvailableMöbius Sequencehttps://ClinicalTrials.gov/show/NCT00856531
130409130409Expiratory Muscle Training for Persons With Neurodegenerative DiseaseCompletedNo Results AvailableParkinson's Disease|Multiple SclerosisDevice: Expiratory Muscle Strength Trainer|Device: sham devicehttps://ClinicalTrials.gov/show/NCT00856518
130410130410Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell TransplantationRecruitingNo Results AvailableHematologic DiseasesDrug: Everolimus and mycophenolate sodiumhttps://ClinicalTrials.gov/show/NCT00856505

* Görseller ve İçerik tekif hakkına sahip olabilir